Ignite Creation Date:
2024-05-06 @ 2:09 AM
Last Modification Date:
2024-10-26 @ 11:14 AM
Study NCT ID:
NCT01983501
Status:
COMPLETED
Last Update Posted:
2020-09-21
First Post:
2013-10-28
Brief Title:
A Study of Tucatinib ONT-380 Combined With Ado-trastuzumab Emtansine T-DM1 in Patients With HER2 Breast Cancer
Sponsor:
Seagen Inc
Organization:
Seagen Inc